Prognostic factors and outcome measures after BRAF-directed targeted therapy of unresectable metastatic BRAFV600E colorectal cancer: a study cohort-level analysis.
Saved in:
| Title: | Prognostic factors and outcome measures after BRAF-directed targeted therapy of unresectable metastatic BRAFV600E colorectal cancer: a study cohort-level analysis. |
|---|---|
| Authors: | Colloca GA; Oncologia Medica & Innovation, Via Aicardi N. 37, 18100, Imperia, Italy.; UOSD Oncologia Territoriale, AUSL di Bologna, Sasso Marconi, Bologna, Italy., Venturino A; Oncologia Medica & Innovation, Via Aicardi N. 37, 18100, Imperia, Italy. vent.ant.470@gmail.com. |
| Source: | Investigational new drugs [Invest New Drugs] 2026 Mar 07. Date of Electronic Publication: 2026 Mar 07. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1573-0646 |
|---|---|
| DOI: | 10.1007/s10637-026-01607-1 |
